Introduction to the advantages, applications and development trends of Westen molecular diagnostic technology

What is molecular diagnosis?

Molecular diagnosis refers to the application of molecular biological methods to detect changes in the structure or expression level of genetic material in patients, thereby making a diagnosis, and is one of the methods for in vitro diagnosis. The main technologies used in molecular diagnostics include PCR, microarrays, hybridization, DNA sequencing, and next-generation sequencing (NGS). Among these technologies, PCR is the most commonly used and currently accounts for the largest market share. However, the analysis predicts that chip technology will grow at the fastest rate within five years (a disadvantage of PCR is that it does not look good. The experiment analyzes a gene, but a phenotype may be associated with many genotypes, so high-throughput chip technology is needed.

Molecular diagnosis breaks the routine diagnosis and treatment mode. Traditional treatment is to apply the same treatment plan to patients with the same type of disease, and then adjust the diagnosis and treatment according to each person's treatment and doctor's experience. Molecular diagnosis can detect individual differences in patients by detecting the molecular characteristics of patients and pushing individualized treatment forward. In addition to predicting the effects of drugs, molecular diagnostics are even more prominent in tumor prediction. Hollywood actress Angelina Jolie detected the susceptibility gene through early molecular diagnosis, so that the breast and ovaries were removed as soon as possible, reducing the possibility of illness.

The molecular diagnostic service industry is a technology-intensive industry that integrates multi-disciplinary technologies such as molecular biology, biochemistry, genetics, immunology, pathology, and informatics. It has high technical thresholds and talent barriers. Chongqing Weisteng Bio-Biomedical Technology Co., Ltd. (hereinafter referred to as “Weisseng Bio”) has been engaged in biotechnology services for many years. It has a complete experimental platform, experienced R&D team, strong technical support, and a number of technical patents. The core R&D team has established a continuous innovation mechanism and talent incentives for technology research and development, and continues to innovate and practice in the molecular diagnostic industry.

Molecular diagnosis has innate advantages in prenatal and postnatal care, non-invasive prenatal genetic testing, and third-generation IVF technology. The Westen Biomolecular Diagnostic Platform is dedicated to the improvement of molecular diagnostic techniques such as the improvement of labeling methods, the replacement of traditional enzyme-free and chemiluminescent technologies with quantum dot fluorescence, high sensitivity, high specificity, good stability, long-term dynamic detection, It can realize the advantages of simultaneous multi-indicator labeling, such as the interaction of Westin Bio-protein nucleic acid to speed up the diagnosis. At the same time, Westen Bio is also committed to the development of new diagnostic kits, such as visual prenatal screening chips and multi-indicator joint detection kits for cancer.

At present, in terms of technology, there is not much difference between China and foreign countries. Due to the high threshold of molecular diagnostic technology, only qualified medical institutions or laboratories can do the job. In recent years, domestic molecular diagnostic technology has achieved rapid development. The state has invested a large amount of research funding. The domestic research level is not much different from the international advanced level. However, China's molecular diagnosis has not been applied in large scale in clinical practice.

Weisseng Bio is not just doing research and development, but developing products, industrializing knowledge, shortening the distance between technology and products, and shortening the distance between molecular diagnostic products and consumer groups!